We are live on ! Find out more
ELVN icon

Enliven Therapeutics

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$125M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$71.4M +$18.2M +1,485,029 +40%
5VM
3
5AM Venture Management
California
$71.4M
VA
4
VR Adviser
New York
$40.9M
CC
5
Commodore Capital
New York
$40.2M
Citadel Advisors
6
Citadel Advisors
Florida
$33.1M +$526K +42,957 +2%
FFM
7
Fairmount Funds Management
Pennsylvania
$29.5M
RCM
8
RA Capital Management
Massachusetts
$29.4M
BlackRock
9
BlackRock
New York
$25.6M +$3.45M +282,126 +18%
Vanguard Group
10
Vanguard Group
Pennsylvania
$17M +$967K +79,071 +7%
BC
11
Boxer Capital
California
$8.94M
State Street
12
State Street
Massachusetts
$6.71M +$167K +13,663 +3%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$6.43M +$388K +31,685 +7%
Janus Henderson Group
14
Janus Henderson Group
$5.68M +$1.62M +132,098 +48%
WP
15
Woodline Partners
California
$5.48M
LGM
16
Logos Global Management
California
$4.25M
Northern Trust
17
Northern Trust
Illinois
$3.11M +$370K +30,278 +16%
Morgan Stanley
18
Morgan Stanley
New York
$2.2M +$1.53M +125,072 +368%
Charles Schwab
19
Charles Schwab
California
$2.19M +$22.1K +1,809 +1%
HS
20
HighVista Strategies
Massachusetts
$1.9M +$155K +12,654 +10%
ACP
21
Acuta Capital Partners
California
$1.71M +$248K +20,276 +20%
Nuveen
22
Nuveen
North Carolina
$1.2M -$4.13K -338 -0.4%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$1.11M -$7.71K -630 -0.8%
BCM
24
BML Capital Management
Indiana
$692K
Barclays
25
Barclays
United Kingdom
$582K +$348K +28,449 +209%